Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020219 | PMC |
http://dx.doi.org/10.3389/fmicb.2022.897612 | DOI Listing |
Insights Imaging
January 2025
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Bladder cancer is the 10th most common and 13th most deadly cancer worldwide, with urothelial carcinomas being the most common type. Distinguishing between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) is essential due to significant differences in management and prognosis. MRI may play an important diagnostic role in this setting.
View Article and Find Full Text PDFFront Cardiovasc Med
November 2024
Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Intensive Care Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Eur J Prev Cardiol
December 2024
Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Front Oncol
November 2024
Cedars Sinai Medical Center, Los Angeles, CA, United States.
Pancreatic Ductal Adenocarcinoma (PDAC) is an exceptionally deadly form of pancreatic cancer with an extremely low survival rate. From diagnosis to treatment, PDAC is highly challenging to manage. Studies have demonstrated that PDAC tumors in distinct regions of the pancreas exhibit unique characteristics, influencing symptoms, treatment responses, and survival rates.
View Article and Find Full Text PDFFuture Sci OA
December 2024
Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!